Skip to content

Clinical study of XiaoZhi formula to intervene in non-alcoholic fatty liver disease

Clinical study of a high evidence-based level RCT of XiaoZhi formula intervention in patients with non-alcoholic fatty liver disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073673
Enrollment
Unknown
Registered
2023-07-18
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NAFLD

Interventions

treatment:XiaoZhi formula
control:diet and exercise

Sponsors

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age: 18 to 65 years old, regardless of gender. (2) Meeting both Chinese and Western medical diagnostic criteria. (3) Above the upper limit of normal < serum ALT = 3 times the upper limit of normal. (4) Fasting blood glucose = 7.0 mmol/L. (5) Signed informed consent form. (6) Not taking other drugs for the treatment of NAFLD, or who have discontinued other drugs for the treatment of NASH before 4 weeks of inclusion for observation. Translated with www.DeepL.com/Translator (free version)

Exclusion criteria

Exclusion criteria: (1) viral hepatitis, drug-related liver disease, total parenteral nutrition, hepatomegaly, autoimmune liver disease, etc. (2) Those suffering from serious heart, brain, kidney, hematopoietic system diseases and emotional diseases such as anxiety, depression and psychiatric disorders. (3) Fatty liver caused by long-term use of glucocorticoids, chlorpromazine, insulin, etc. (4) Patients with type I diabetes mellitus. (5) Patients with various types of malignant tumors Translated with www.DeepL.com/Translator (free version)

Design outcomes

Primary

MeasureTime frame
MRI-PDFF;

Secondary

MeasureTime frame
ALT;AST;ALP;?-GT;TC;TG;LDL-c;HDL;FFA;Fe;IR;BMI;Fibroscan;BFR;WHR;

Countries

China

Contacts

Public Contactsun xue hua

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

susan_sxh@shutcm.edu.cn+86 21 2025 6506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026